氨甲环酸在肝硬化静脉曲张出血中应用的研究进展

肝脏 ›› 2024, Vol. 29 ›› Issue (9): 1019-1021.

氨甲环酸在肝硬化静脉曲张出血中应用的研究进展

孙梦雪, 唐敏, 杨长青

200065 上海同济大学附属同济医院消化科, 消化疾病研究所

收稿日期:2024-09-02 出版日期:2024-09-30 发布日期:2024-11-13
通讯作者: 杨长青, Email:cqyang@tongji.edu.cn
基金资助:
国家自然科学基金项目(U22A20275);上海市临床重点专科建设项目(SHSLCZDZK06801)

Received:2024-09-02 Online:2024-09-30 Published:2024-11-13

摘要/Abstract

摘要： 食管胃底静脉曲张破裂出血(EGVB)是肝硬化终末期并发症之一,具有极高的死亡率和再出血率。快速有效的止血对于提高患者生存率、改善预后具有重要意义。氨甲环酸(TXA)作为一种抗纤维蛋白溶解药物,近年来因其显著的止血效果在治疗EGVB中而受到广泛关注。本文旨在综述氨甲环酸在EGVB治疗中的疗效评估、安全性考量及未来研究方向。

关键词: 氨甲环酸, 肝硬化, 静脉曲张破裂出血, 抗纤维蛋白溶解, 止血效果

孙梦雪, 唐敏, 杨长青. 氨甲环酸在肝硬化静脉曲张出血中应用的研究进展[J]. 肝脏, 2024, 29(9): 1019-1021.

/ 推荐

[1] Verma A, Meshram R, Phulware RH, et al. Sudden Death Caused by Gastroesophageal Varices Rupture: Insights From an Autopsy-Based Case Series Unraveling the Pathological Events[J]. Cureus, 2023, 15: e46166.
[2] Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis[J]. J Hepatol, 2022, 76: 1291-1305.
[3] Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study[J]. Hepatology, 2015, 61: 660-667.
[4] Raman KP, Patch D. Tranexamic acid in variceal bleeding revisited[J]. Hepatology, 2024, 80: 257-259.
[5] McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis[J]. Drugs, 2012, 72: 585-617.
[6] Barrett CD, Neal MD, Schoenecker JG, et al. Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again[J] ? Transfusion, 2024, 64 Suppl 2: S11-S13.
[7] Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients[J]. Health Technol Assess, 2013, 17: 1-79.
[8] Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2017, 389: 2105-2116.
[9] Dunn CJ, GoKa L. Tranexamic acid: a review of its use in surgery and other indications[J]. Drugs, 1999, 57: 1005-1032.
[10] Barrett CD, Moore HB, Kong YW, et al. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner[J]. J Trauma Acute Care Surg, 2019, 86: 101-107.
[11] Xie CM, Yao YT, He LX, et al. Anti-inflammatory effect of tranexamic acid on adult cardiac surgical patients: A PRISMA-compliant systematic review and meta-analysis[J]. Front Surg, 2022, 9: 951835.
[12] CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial[J]. Lancet, 2010, 376: 23-32.
[13] CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial[J]. Lancet, 2011, 377: 1096-1101, 1101 e1091-1092.
[14] HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial[J]. Lancet, 2020, 395: 1927-1936.
[15] Kumar M, Venishetty S, Jindal A, et al. Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: A randomized controlled trial[J]. Hepatology, 2024, 80: 376-388.
[16] Taeuber I, Weibel S, Herrmann E, et al. Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression[J]. JAMA Surg, 2021, 156: e210884.
[17] Perel P, Ker K, Morales Uribe CH, et al. Tranexamic acid for reducing mortality in emergency and urgent surgery[J]. Cochrane Database Syst Rev, 2013, 2013: CD010245.
[18] Lamy A, Sirota DA, Jacques F, et al. Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial[J]. Circulation, 2024,
[19] Dong W, Tang Y, Lei M, et al. The effect of perioperative sequential application of multiple doses of tranexamic acid on postoperative blood loss after PLIF: a prospective randomized controlled trial[J]. Int J Surg, 2024, 110: 2122-2133.
[20] Delaney M, Wendel S, Bercovitz RS, et al. Transfusion reactions: prevention, diagnosis, and treatment[J]. Lancet, 2016, 388: 2825-2836.
[21] Gluud LL, Klingenberg SL, Langholz SE. Systematic review: tranexamic acid for upper gastrointestinal bleeding[J]. Aliment Pharmacol Ther, 2008, 27: 752-758.
[22] Zhang P, Li J, Wang X. Combined versus single application of tranexamic acid in total knee and hip arthroplasty: A meta-analysis of randomized controlled trials[J]. Int J Surg, 2017, 43: 171-180.

氨甲环酸在肝硬化静脉曲张出血中应用的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘翠翠, 贺薏, 邱婧琦, 梁爽, 王倩, 张志博. 超声造影评估肝硬化小肝癌的价值及其与血清AFP-L3、GPC3、GP73水平的关系[J]. 肝脏, 2024, 29(9): 1056-1059.
[2]	申友书, 代梅, 赵菲, 杨平. 住院肝硬化患者人体测量学指标及营养状态分析[J]. 肝脏, 2024, 29(9): 1077-1080.
[3]	华静, 潘亚杰, 吕雪艳, 陈如悦, 曾庆磊. 肝硬化合并乳糜性胸腹水诊断和治疗的病例系列研究[J]. 肝脏, 2024, 29(9): 1081-1084.
[4]	孙梦秋, 张爱霞, 张莉, 林子曦. 血栓弹力图参数评估乙型肝炎肝硬化合并食管胃底静脉曲张破裂出血的意义[J]. 肝脏, 2024, 29(9): 1091-1095.
[5]	丹巴玉珍, 王婉婷. 乙型肝炎肝硬化门静脉高压症患者食管静脉曲张侧支循环的CT灌注成像研究[J]. 肝脏, 2024, 29(9): 1096-1099.
[6]	刘源, 李玉瑶, 鲁冰洁, 钱平安, 聂红明, 沈婷婷. 肝硬化患者肌少症的中西医诊疗研究进展[J]. 肝脏, 2024, 29(9): 1141-1145.
[7]	邱原元, 张敏, 项伟艳. 基于超声造影定量参数、超声血流参数构建肝硬化并发门静脉血栓的诊断模型[J]. 肝脏, 2024, 29(8): 905-909.
[8]	张旭辉, 孟繁坤. 负荷超声心动图在评估肝硬化患者左心功能储备中的应用[J]. 肝脏, 2024, 29(8): 910-913.
[9]	李小玲, 杜海刚. 乙型肝炎肝硬化腹水患者SAAG及血清LDH、CA199、CA125水平观察[J]. 肝脏, 2024, 29(8): 914-918.
[10]	孙颖, 孔燕, 赵丹妹, 陈应清. 乙型肝炎肝硬化患者血清miR-122水平与肝纤维化程度的关系[J]. 肝脏, 2024, 29(8): 924-928.
[11]	周培玉, 吴怡. MRI多b值成像联合64排螺旋CT在乙型肝炎肝硬化患者肝脏再生结节诊断中的价值[J]. 肝脏, 2024, 29(8): 929-933.
[12]	胡静, 易庭庄, 农欣蕾, 王统华. 血清学指标联合Child-Pugh评分对肝硬化食管静脉曲张破裂出血患者EVL术后再出血的预测价值[J]. 肝脏, 2024, 29(8): 934-938.
[13]	王永薇, 刘世恒, 张玉果. 肠菌移植在肝病治疗中的研究进展[J]. 肝脏, 2024, 29(8): 1002-1004.
[14]	张嘉欣, 韩文, 葛彪, 白莆菥. 肝硬化食管胃底静脉曲张无创预测的研究进展[J]. 肝脏, 2024, 29(8): 1005-1009.
[15]	余姣, 万谟彬. 慢性乙型肝炎患者中丁型肝炎病毒共感染的筛查与治疗研究进展[J]. 肝脏, 2024, 29(7): 762-766.